ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,941Medicare Part D Prescriptions Filled, Including Refills

Rank: 221 out of 3734

$926K Total Retail Price of All Prescriptions

Rank: 131 out of 3734

437 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 437 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 12,112 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
ATORVASTATIN CALCIUM 588 535 1 11
METOPROLOL TARTRATE 554 498 2 6
LEVOTHYROXINE SODIUM 504 448 3 2
FUROSEMIDE 488 449 4 7
WARFARIN SODIUM 450 375 5 10
SIMVASTATIN 448 378 6 1
OMEPRAZOLE 320 247 7 4
METFORMIN HCL 315 273 8 8
AMLODIPINE BESYLATE 313 297 9 5
HYDROCODONE-ACETAMINOPHEN 298 245 S3 10 12
POTASSIUM CHLORIDE 262 260 11 19
LISINOPRIL 247 229 12 3
PANTOPRAZOLE SODIUM 246 224 13 22
CLOPIDOGREL 245 224 14 23
DONEPEZIL HCL 219 219 15 25
NAMENDA 214 214 16 44
DIGOXIN 203 191 17 43
QUINAPRIL HCL 184 137 18 74
AMLODIPINE BESYLATE-BENAZEPRIL 182 157 19 56
HYDROCHLOROTHIAZIDE 173 158 20 9
PLAVIX 160 145 21 39
TAMSULOSIN HCL 147 135 22 29
METOPROLOL SUCCINATE 143 122 23 14
ATENOLOL 138 127 24 13
CITALOPRAM HBR 136 108 25 16
DIOVAN HCT 131 131 26 72
NEXIUM 129 107 27 36
BISOPROLOL-HYDROCHLOROTHIAZIDE 121 98 28 145
METFORMIN HCL ER 121 102 28 66
GLYBURIDE 118 102 R 30 64
DIOVAN 113 112 31 31
ISOSORBIDE MONONITRATE ER 108 106 32 34
CELEBREX 103 86 33 69
CRESTOR 102 67 34 28
INSULIN SYRINGE 100 100 35 109
LANTUS 96 91 36 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 81 36 27
SPIRONOLACTONE 79 68 38 80
LANTUS SOLOSTAR 78 65 39 102
PREDNISONE 77 74 40 42
LIPITOR 76 57 41 90
ONGLYZA 76 60 41 211
GLIPIZIDE 71 60 43 57
PAROXETINE HCL 69 67 44 59
TRAZODONE HCL 68 38 45 49
SERTRALINE HCL 68 68 45 18
ZETIA 66 43 47 55
BYSTOLIC 66 51 47 148
CLONIDINE HCL 66 48 47 79
ALLOPURINOL 65 54 50 33
ESCITALOPRAM OXALATE 63 62 51 68
NOVOLOG 63 56 51 112
ADVAIR DISKUS 61 56 53 35
ALENDRONATE SODIUM 58 48 54 26
AZITHROMYCIN 57 43 55 38
ZOLPIDEM TARTRATE 56 37 56 24
TOPIRAMATE 54 28 57 181
LEVETIRACETAM 53 37 58 105
SPIRIVA 53 41 58 40
CIPROFLOXACIN HCL 52 47 60 77
CARVEDILOL 52 43 60 30
CYMBALTA 52 28 60 67
FAMOTIDINE 51 39 63 60
AGGRENOX 50 50 64 182
GABAPENTIN 50 37 64 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.